Chemoinformaics analysis of 8ALPHA-8-HYDROXY-12-OXO-13-ABIETEN-18-OIC ACID
| Molecular Weight | 334.456 | nRot | 2 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 18 |
| Exact Molecular Weight | 334.214 | nRing | 3 |
| Solubility: LogS | -3.879 | nHRing | 0 |
| Solubility: LogP | 2.797 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 56.6118 |
| nHD | 2 | BPOL | 31.8322 |
| QED | 0.809 |
| Synth | 4.474 |
| Natural Product Likeliness | 2.603 |
| NR-PPAR-gamma | 0.583 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.018 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -5.099 |
| MDCK | 0.0000202 |
| BBB | 0.716 |
| PPB | 0.904673 |
| VDSS | 0.406 |
| FU | 0.120788 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.83 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.768 |
| CYP2c9-inh | 0.082 |
| CYP2c9-sub | 0.406 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.12 |
| CYP3a4-inh | 0.078 |
| CYP3a4-sub | 0.177 |
| CL | 1.135 |
| T12 | 0.427 |
| hERG | 0.007 |
| Ames | 0.042 |
| ROA | 0.263 |
| SkinSen | 0.11 |
| Carcinogencity | 0.355 |
| EI | 0.416 |
| Respiratory | 0.942 |
| NR-Aromatase | 0.493 |
| Antiviral | Yes |
| Prediction | 0.648145 |